Deadline: 6 January 2026
The Israel Cancer Research Fund is seeking applications for its ICRF Israel Grant Program to support the best cancer-related research conducted by Israeli scientists in Israel.
ICRF supports basic, translational, and clinical cancer research. All research must be conducted in Israel, except in the case of clearly-identified, international collaborative grants. To apply for an ICRF grant, an investigator must be a citizen of Israel (proof of Israeli citizenship must be furnished upon request).
ICRF funds cannot be used for salary of the PI or Co-Investigators, for clerical or other administrative expenses, for overhead charges, or for work performed outside of Israel. There are several changes to ICRF grant categories in the 2026–2027 funding year: The Acceleration Grant category is being discontinued. Research Career Development Awards (RCDAs) and Clinical Research Career Development Awards (CRCDAs) will be merged into a single Career Development Awards (CDA) category.
The Career Development Awards (CDAs) are designed to enhance the research capabilities of young Israeli scientists in the formative phase of their careers who have demonstrated outstanding potential for contribution to cancer research as independent investigators.
CDAs are available to investigators with clear research potential who will benefit by additional mentored experience in a scientific environment that is conducive to the development of an independent research career.
A candidate must have a doctoral degree and at least three years of postdoctoral fellowship or equivalent experience, hold an independent junior position at an Israeli institution, and be within five years of initial appointment to that position at the start date of requested funding. Awards are made for three years at a maximum stipend of $45,000 per year and are not renewable.
The Project Grants provide funding for projects of high scientific merit and clear potential significance for advancing the understanding, diagnosis, or treatment of cancer. These grants are intended to support the research of established investigators working in areas in which they have demonstrated expertise.
The applicant must be an independent investigator who has demonstrated the ability to lead a research team, as evident in their Biosketch and Publication Record. While multi-investigator applications and interdisciplinary approaches are encouraged, they are not mandatory.
Applications must focus on questions related to human cancer supported by strong published or preliminary data that provide a solid foundation for future progress. Funding priority is typically given to projects with potential to impact prevention, diagnosis, or treatment of cancer in the next five to ten years.
Awards are made for three years at a maximum stipend of $60,000 per year. Current Project Grant recipients are encouraged to reapply for continued funding during the final year of the award to ensure continuity if selected.
The Research Professorship Grants recognize accomplished investigators whose research has had a significant impact on the understanding of cancer and whose commitment to fundamental issues in the field serves as an inspiration to others.
Applicants must hold the rank of Full Professor or equivalent and have at least eight years of research experience since obtaining their PhD, MD, or MD/PhD degree. Grants are awarded for five years with a maximum stipend of $100,000 per year.
The application process for Research Professorship Grants involves three components: applying for a three-year Project Grant through ICRF’s online application form in Proposal Central, describing research objectives for Years 4 and 5 of the Research Professorship funding, and outlining qualifications for the Professorship.
For more information, visit ICRF.
